JOSÉ TOMÁS
RAMOS AMADOR
Catedrático de universidad
University of Padua
Padua, ItaliaPublicaciones en colaboración con investigadores/as de University of Padua (14)
2022
-
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Medicine, Vol. 23, Núm. 2, pp. 186-196
2020
-
Clinical outcomes of a zika virus mother–child pair cohort in Spain
Pathogens, Vol. 9, Núm. 5
2019
-
Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: A European survey of 38 paediatric specialists
Journal of Viral Hepatitis, Vol. 26, Núm. 8, pp. 961-968
2018
2016
-
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption
AIDS, Vol. 30, Núm. 7, pp. 1075-1081
-
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project
BMC Infectious Diseases, Vol. 16, Núm. 1
2013
-
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children
AIDS and Behavior, Vol. 17, Núm. 1, pp. 193-202
-
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants
AIDS, Vol. 27, Núm. 6, pp. 991-1000
2012
-
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers
British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283
2009
-
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants
AIDS, Vol. 23, Núm. 5, pp. 597-604
2008
-
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608
2002
-
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial
Journal of Infectious Diseases, Vol. 186, Núm. 3, pp. 312-320